Case 3: Molecular Testing in Stage III NSCLC
Case 3: 63-Year-Old Man With Unresectable Stage IIIA NSCLC
Case 2: Treatment After Progression of EGFR+ NSCLC
Case 2: EGFR+ NSCLC Combination Therapies
Case 2: FLAURA Study for EGFR+ Metastatic NSCLC
Case 2: EGFR-Positive Non–Small Cell Lung Cancer
Case 2: Biomarker Testing for Non–Small Cell Lung Cancer
Case 2: 67-Year-Old Woman With EGFR+ Non–Small Cell Lung Cancer
Case 1: Small Cell Lung Cancer in the Era of Immunotherapy
Case 1: Biomarkers in Small Cell Lung Cancer
Case 1: CASPIAN Trial in Extensive-Stage Small Cell Lung Cancer
Case 1: IMpower133 Trial in Small Cell Lung Cancer
Case 1: Extensive-Stage Small Cell Lung Cancer Background
Case 1: 72-Year-Old Woman With Small Cell Lung Cancer
Clinical Cases in Lung Cancer
Experts in lung oncology review 3 clinical cases and discuss individualized treatment approaches for each patient.
Limitations in Treating R/R Mantle Cell Lymphoma
MRD Assessment in Mantle Cell Lymphoma
KTE-X19 for R/R MCL: Treatment Considerations
Implications of ZUMA-2 in R/R Mantle Cell Lymphoma
KTE-X19 Treatment for R/R Mantle Cell Lymphoma
Novel Therapies for Mantle Cell Lymphoma
Risk Stratification of Mantle Cell Lymphoma
Investigational Therapy in Mantle Cell Lymphoma: KTE-X19 CAR T-Cell Therapy
Michael Wang, MD, reacts to recent data and the potential to treat patients with relapsed or refractory mantle cell lymphoma with KTE-X19, an investigational CAR T-cell therapy.
Novel Therapies on the Horizon in HER2+ Breast Cancer
HER2-Targeted Therapies in Breast Cancer: Managing AEs
Adherence to HER2-Targeted Therapies in Breast Cancer
Treating Early HER2+ Breast Cancer: KRISTINE
Treating Early HER2+ Breast Cancer: KATHERINE
Selecting HER2-Targeted Therapy for Early Breast Cancer
Dual HER2 Blockade in Early Breast Cancer